Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,635 | 150 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $533.97 | 29 | $0 (2023) |
| PFIZER INC. | $248.82 | 15 | $0 (2024) |
| Novo Nordisk Inc | $245.76 | 16 | $0 (2023) |
| Lilly USA, LLC | $216.70 | 12 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $183.30 | 6 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $176.98 | 12 | $0 (2023) |
| Amgen Inc. | $101.56 | 6 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $91.35 | 5 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $75.67 | 4 | $0 (2023) |
| Corium, LLC | $73.92 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $36.51 | 2 | PFIZER INC. ($36.51) |
| 2023 | $1,702 | 100 | ABBVIE INC. ($351.08) |
| 2022 | $897.08 | 48 | Biohaven Pharmaceutical Holding Company Ltd. ($183.30) |
All Payment Transactions
150 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/19/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/21/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: VACCINES | ||||||
| 11/21/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/15/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/31/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2023 | Supernus Pharmaceuticals, Inc. | TLANDO (Drug), XYOSTED | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/19/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.72 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $23.11 | General |
| 10/18/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/13/2023 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Analgesic | ||||||
| 10/12/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Gastroenterology | ||||||
| 10/10/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: PSYCHIATRY | ||||||
| 10/05/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Diabetes | ||||||
| 10/04/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Diabetes | ||||||
| 10/03/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Respiratory | ||||||
| 09/29/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: PAIN | ||||||
| 09/22/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/19/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: VACCINES | ||||||
| 09/14/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/13/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: UROLOGY | ||||||
| 09/08/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/07/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: CNS Stimulant for ADHD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 209 | 261 | $83,975 | $18,401 |
| 2022 | 11 | 345 | 395 | $125,285 | $23,627 |
| 2021 | 3 | 82 | 295 | $72,108 | $24,572 |
| 2020 | 2 | 82 | 189 | $60,816 | $13,866 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 95 | 141 | $51,747 | $9,521 | 18.4% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 18 | 18 | $7,704 | $2,516 | 32.7% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 18 | 18 | $4,860 | $2,092 | 43.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 40 | $10,400 | $1,730 | 16.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 16 | 16 | $5,952 | $1,692 | 28.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 11 | 12 | $3,168 | $814.50 | 25.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 16 | 16 | $144.00 | $35.20 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 125 | 158 | $60,032 | $8,903 | 14.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 76 | 87 | $23,414 | $3,867 | 16.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 13 | 13 | $3,576 | $3,513 | 98.2% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2022 | 19 | 19 | $8,132 | $2,666 | 32.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 27 | 29 | $15,549 | $1,829 | 11.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $5,956 | $1,330 | 22.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 16 | 16 | $6,207 | $894.37 | 14.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 12 | $1,044 | $343.08 | 32.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 12 | 16 | $677.76 | $132.37 | 19.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 12 | $507.60 | $104.26 | 20.5% |
| 81003 | Automated urinalysis test | Office | 2022 | 21 | 21 | $189.00 | $46.26 | 24.5% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2021 | 25 | 154 | $34,650 | $13,969 | 40.3% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 24 | 102 | $26,928 | $6,236 | 23.2% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 33 | 39 | $10,530 | $4,366 | 41.5% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2020 | 28 | 83 | $22,174 | $5,113 | 23.1% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Office | 2020 | 19 | 44 | $17,444 | $3,988 | 22.9% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2020 | 20 | 36 | $14,256 | $3,177 | 22.3% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2020 | 15 | 26 | $6,942 | $1,589 | 22.9% |
About Syreeta Van Ross
Syreeta Van Ross is a Family healthcare provider based in Independence, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2007. The National Provider Identifier (NPI) number assigned to this provider is 1063539823.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Syreeta Van Ross has received a total of $2,635 in payments from pharmaceutical and medical device companies, with $36.51 received in 2024. These payments were reported across 150 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($2,635).
As a Medicare-enrolled provider, Van Ross has provided services to 718 Medicare beneficiaries, totaling 1,140 services with total Medicare billing of $80,466. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Primary Care, Primary Care
- Location Independence, MO
- Active Since 03/24/2007
- Last Updated 11/10/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1063539823
Products in Payments
- UBRELVY (Drug) $246.91
- NURTEC ODT (Drug) $213.54
- VRAYLAR (Drug) $202.23
- Rybelsus (Drug) $130.45
- ELIQUIS (Drug) $114.08
- MOUNJARO (Drug) $107.94
- FARXIGA (Drug) $100.48
- EMGALITY (Drug) $77.90
- BREZTRI (Drug) $76.50
- Azstarys (Drug) $73.92
- Kerendia (Drug) $61.82
- GEMTESA (Drug) $59.04
- XARELTO (Drug) $55.36
- QUVIVIQ (Drug) $55.19
- PREVNAR 13 (Biological) $54.55
- QULIPTA (Drug) $53.58
- Ozempic (Drug) $50.05
- BELSOMRA (Drug) $48.58
- EVENITY (Biological) $46.41
- JARDIANCE (Drug) $39.74
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Independence
Mrs. Laura Badami, Np-C, NP-C
Family — Payments: $9,647
Lashun Robinson, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $6,558
Christina Turner
Family — Payments: $6,135
Mrs. Deborah Truesdell, Aprn, APRN
Family — Payments: $5,900
Kristen Muscarello, Np, NP
Family — Payments: $4,708
Mrs. Lacy Mills, Fnp, FNP
Family — Payments: $4,571